Content uploaded by Herve Seligmann
Author content
All content in this area was uploaded by Herve Seligmann on Jul 05, 2021
Content may be subject to copyright.
08V2021 version 3
Expert evaluation on adverse eects of the Pzer-COVID-19 vaccination
!
"##$%
&'
!(&
)*+&
&,-.)
$/%0&
1
('2
&
Overview
+$0*
&&$
$03
(
1(
4
3$
5$6#$
($
$0
76#$8#$
9#:6#$6;
<!6#!
"##:,
3
%=>."8$
(
&
&
4$0$=>."8
$=>."8$$
%7""
2%""(
,$&0&
=>."8
9?;5"@"A,666B
2A68A5@66?6?5B
!=>."8C
(
3=>."8
+
$0'
$
036,@27""B
5@%""B(3
'3
&(
$0
)*+
&
+)*+$&>
&>!
">&
$
'&
(
!$&
($$
6$)*+
)*+
)*+
5%$&
3
;)*+
D
+
)*+$E.*+
("8?9*'
-
)%
@("B.4@
.6#6"B3,$&
<
.C-0'-0'
%
Preliminary cost-benece evaluation of COVID19 vaccination
("6
0
3
'3(3
33(
&
("%
27""(6
%""
F$=>."8
("79#0";"
C";9
(!";9!";G
6#;;=>."8
$0#0"C+
5&"C
6;65!?G
"989"=>."8(0&
6C69A,!?G"A?8,
=>."8!=>."8
(&6C"A5A!?G
"6A99#$
098#96=>."8
*=>."8
%
.
(
.
.HH
.H
E9#
"5#?,
56
5 5"; A9, "A5
95
9
",58
9
" "#?6;
6,
8 6?? ?;6 ",6
,;
9
"6?#
#
#$"5 965,
";
? "99 ;9, A"
5;
; ?;5A "; ###55#5 ";9#
E"5 ;;A8
""
6 """ 6?? ?"
6#
6 ,696 ? ###,;A; 6;65
6 65," 9; 5? "65 5" 8# 6989
#$9 "#;5 6; "" ,? "5 ," ""88 ? ###9#?9 69A,
?$"; "#5? 56 6, ,9 "? 5, "6#6 ? ###;"9 "A5A
E"; 6?" A " "# " ; 68, 8 ###",#? 999
I9#
6A#"A
"5
A 86 "99 5? 6;
6A;?
,
" 6,869
"6
, A? ",5 5; 66
695;
?
#$"5 "8;9" 89 99 "6; 68 "?
"8?8
5 "; #####9"5 65A9
E"5 9;95 68 6" 68 , , 9,,6 ? ####"#8 ;6;#
6 6
6 6#86 "5 , "5 5 6 6"6A
#$9 ""9? A # ; " 6 ""A6 ? ####6;"? 8;##
?$"; ?9" ; ; A 6 # ??8 ? #
E"; "9; " " " # # "9? 8 #
+ ;"#85
;9
" ;#9 "#5" 66#
99
#
;5A?
"
/E9#
####6695
"
/I9#
######6,
?
("=>.$"8
7""=.
5#5%".6#
@J5?;?9#5#88B
-@9#
B$0
%666#6"@
"6B
JHHHHKHH-HKK!@
9#""#;8:=>."88"96:=>."8B
(9#
8;!?G9,A
=>."8-
3
5
$=>."8$9,A
=0
9,A)*+
+
-0'0
F$0(6(
(".6"$
6C=>."8""9,
""9,!6"G6;;9,
=>."8!
"+0?
6C";A6!?G"8,;;+
690&6C
";88!69G5A8?;
=>.$"8L>
/ "
6I?
6E?
@B 5,A;,; ,",?" ?9?, ;966
56,? ,A? "## "#9
% ";,; ;99 ,; ,8
55A" "#A5 "9, ";8
?"; "?6 "? 5?
. ",99 ?#8 A; "#,
( 59AA69 ,;,AA A#8, ,#?A
. A# 6" ? M69@"$
,6B
.HH"#### #,5" 9"A ";A6 ?8,@6"#$
58AB
%
""9, 6?86 ";88@58#$
?;8B
- 8?"8 8;;? 8;A" 8"#6
-H
##5,6
#6956
#?;"6 #5;,;@A8A$
#"?B
H
?;8 6"#8 8A5@6,,;9$
;8"B
(6(JHHH&&H6#6"H#5H""H$"8$$
$$$$'$&$;#$$$&H.
%=>.$"8.6#
%"#(<=
%0-I####"
!$
(6A68A5
=>."8$
=>."8
(0-0'
6?6A
)*+(
0C
Extrapolating increased vaccination-associated risks for younger, yet
unvaccinated age groups
*",
!&
(&=>."8$
3
$!
0>
(
3(
=>."8
(
>+<)
"88#6#6#7"+%3
+!"?,0
&$
"7"4
55
(0$
=>."8
5#=>."8
7"(
=>."8
+
7">+4"88#
6#6#N6#6"76#6"
6#6#@J/>+<)B
(
(!=>."8
=>."8$$
6#7"!
($>+<)
0=>."8$$
+ 6#
$
6;
6,$
68
5#$
5;
5,$
58
;#$
;;
;,
$
;8
,#$
,;
,,
$
,8
9#
$
9;
9,$
98
?#$
?;
?,$
?8
A#$
A;
A,$
A8
8#O
6#6# 6? 55 ;# ;6 ?A "6 ";A 6, 58 ,5 ?8 ?6 "6" "55 "?#
? # ? 9 " , A 6 #
6#6" ;; ;, ;8 99 86 "6
5
"?6 6?
6
;5
,
9#
6
8?
A
A8
8
"6A
;
"5?
"
"??
#
:
95 59
;
66
,
,?
"
"?
8
$
5
"
"9
6
A
A
8
9
"6
5
65
9
6; ,; 68 ;"
(5.6#7;$%6#6#
@=>."8B6#6"
@=>."8"8"97;
6#6"B$&@J
4B
(6#6"6#6#
@76B<!I6#@76B
I6#0$
>+<)7"*
"
76-,
6#7$%6#6"7$%6#6#
(5
=7$%
6#6"6#6#=>."8
=>."8F"
60=>."8
$0=>."8("
6+
"57$
%6#6"6#6#$0=>."8
6#6#C6
6#6"(,
F$0=>."8
7$%6#6"6#6#(
=>."8=>."8
75$037$
%6#6#6#6"
"6
=>."86#6#(!
85?8:!
!(
75!6#
6#6"6#6#
7
75+$0!7$%6#6"6#6#
$0=>."8!6
(=>."87$%6#6"
75"A6A#$8"A","#$"8(65A
68,$0=>."8
7;
)(
7$%6#6"6#6#
$0=>."8F
=>."8$
6#=>."8($
;#F
,#7$%6#6"
.6#6#$N6#6"
7;)!7$%6#6"
6#6#(7!"
"#
*7$%6#6"
!(
3
57"!
7;65A
Increased COVID19 infection rates between 1st and 2nd injections
F?.
4@.6#6"B*<N%75
5$=>.$"80?
0C(
6#6A0C
5,0C
";=>.$"8
.(&
5&75
,$&
!$5$&
'6$&"C
4$$0
7,.=>.$"8"4J
"=>.$"8PJ-I##,..*<N
%6#6"Q"#"#,9H*<N%6"#"?9,
Vaccination against COVID19 drives COVID19 spread
=>."80&0-0'
C@7,B
=>."85$&
F
!C
.6#6#6#=>.JA5?;86
95;9.$F@B
C@=>.$"8B
>$)$=F.+66
6#6"
-D=>."8
+8$6"@"AA"5?"6666,"?9"?#6#6";6"9,"?""58
"5,B"5
@(;6B
L
-
# ##99 $#"86
" #;88P $#55,
6 $##A" $#"8;
5 $##96 $##,8
; #68" ##;9
, ##?" $##"?
9 $##8A #6;A
? #5", #9;#PP
A #,5"PP
#?"6PP
8 $#"?; $#"9;
"# $#"9; $
#9;;PP
"" #6;9 $#5";
"6 $#5"9 ##,?
"5 $#6"5 #"69
"; #6,6 #;98
", #";" ##"A
"9 $#55, $##A#
"? $
#,?;PP
$#68,
"A #6;5 $#6,5
"8 #6"? #56"
6# $
#9#,PP
#;,;
6" #6?# ##"9
66
#,;#PP
$#"#6
65 $#"#9 $#"6#
6; ##"6 $#68?
6, #5#9 $##A;
69 $###A #6;A
6? $#"?8 #5#?
6A #;?# ##?5
68
#?6#PP
#69"
5# $##;8 $#6?6
(;-D=>.
@+8$6"B&
"5+6"@6B
-@+""$655BPJ-I##,QPPJ-I##,C
@4C"88,B6$
(
A=>."8
@79B*
"?6#
6C(
66686C
+6#:-
+!@+
65$%?B
=>."8"5@+""$65,996?";#A9A;
,#",,59;8;;"66#;6;9"#959,#9B
&68
@(;5B>
@G#9;-G###8QG#,5"-G
##5"$B
.=>."8&
%&
(?
(;
79.=>."8@+8$6"B
@+"$"5B>
!$!
.+6#6"-0$
=>."8C
C-0'
-
-0'R
(7,9(;0
$=>."8
(1'
$&$
=>."83=>."8
C=
=>."8!F
$$@5,B/+@
;#BC
=>."8
-I##,";"?7/+
-I##,5$,@7?
F;B
(3
=>."8
3%&133
(
&6&=>."8
7?.=>."8@+"6$6;B"
@+A$6#B7
!!$!
Overall conclusions
4@("6%
.76B
3(0'
@("",
B(.
(
4C3
!3(
$@5$B@6#
=>.$B
$0
&
=>."8$&,$&
$
"6C!
C
$&=>."8
$
6,=
!&
$3
)*+>
&*$&
=>."8&!
<!0
(0
&)$
C$$$0
$0
>$&!6#
6#=>."8$&
C
A$%$6"
